解析吸烟与系统性硬化症的关系:基于EUSTAR队列的分析
在EUSTAR队列12314例系统性硬化症患者中,比较吸烟者与从不吸烟者的自身抗体状态及疾病进展。男性吸烟与死亡率升高相关(HR 1.63),女性吸烟与皮肤进展及任何器官进展风险升高相关,吸烟者抗拓扑异构酶抗体阳性率较低。在ACA阳性及ATA阳性患者中,吸烟均为死亡、皮肤进展和任何器官进展的危险因素。
要点
- 男性SSc患者中吸烟与死亡率升高相关(HR 1.63,95%CI 1.23-2.16),女性中未见此关联。
- 女性吸烟者皮肤进展风险(HR 1.10)和任何器官进展风险(HR 1.07)升高。
- 吸烟者ATA阳性率较低(女性从不吸烟者34% vs 吸烟者21%),且包年数和吸烟时长与ATA阳性率降低相关。
核心结论
- 分层分析显示吸烟与男性SSc患者死亡率升高相关,但与女性死亡率无关。
- 吸烟与ATA阳性率降低相关,尤其在女性中表现显著。
- 在ATA阳性和ACA阳性患者中,吸烟均为死亡、皮肤进展和任何器官进展的危险因素。
研究设计与样本
- 在欧洲硬皮病试验与研究(EUSTAR)队列中开展的分析,共纳入12314例系统性硬化症患者。
- 比较吸烟者与从不吸烟者的自身抗体状态,采用Kaplan-Meier曲线评估疾病进展时间,构建Cox模型分析15年随访期间吸烟的影响。
- 所有分析在总队列中进行,并按性别及抗着丝点抗体(ACA)和抗拓扑异构酶抗体(ATA)阳性状态分层。
主要发现
- 总队列12314例中,女性10393例(84%),ACA阳性4637例(38%),ATA阳性3919例(32%),吸烟者4271例(35%)。
- 男性吸烟者死亡率HR 1.63(95%CI 1.23-2.16,p=0.001),女性吸烟者皮肤进展HR 1.10(95%CI 1.00-1.22,p=0.046),任何器官进展HR 1.07(95%CI 1.00-1.13,p=0.036)。
- 女性从不吸烟者ATA阳性率34%,吸烟者21%(p<0.001);吸烟者中包年数越高ATA阳性频率越低(OR 0.98,95%CI 0.97-0.99,p<0.001),吸烟时长越长ATA阳性频率越低(OR 0.96,95%CI 0.95-0.97,p<0.001)。
- ACA阳性吸烟者死亡率HR 1.29(95%CI 1.02-1.63,p=0.033),心脏受累HR 1.25(95%CI 1.03-1.43,p=0.001),皮肤进展HR 1.21(95%CI 1.03-1.42,p=0.018),任何器官进展HR 1.14(95%CI 1.05-1.24,p=0.002)。
- ATA阳性吸烟者死亡率HR 1.40(95%CI 1.10-1.78,p=0.006),皮肤进展HR 1.19(95%CI 1.03-1.37,p=0.020),指端溃疡HR 1.17(95%CI 1.02-1.34,p=0.029),任何器官进展HR 1.11(95%CI 1.00-1.22,p=0.048)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To untangle the association between smoking and systemic sclerosis (SSc). METHODS: In the European Scleroderma Trials and Research cohort, the autoantibody status was compared between ever-smokers and never-smokers. Time until disease progression was assessed using Kaplan-Meier curves. Cox models were built to investigate the influence of smoking over 15 years of follow-up. All analyses were performed for the total cohort and stratified for sex and for positivity of anti-centromere (ACA) and anti-topoisomerase antibodies (ATA). RESULTS: Overall, 12 314 patients were included in the study. Of these, 10 393 were women (84%), 4637 were ACA-positive (38%), 3919 were ATA-positive (32%) and 4271 (35%) were ever-smokers. In men, but not in women, smoking was associated with mortality (HR 1.63, 95% CI 1.23 to 2.16, p=0.001). Ever-smoking women were at higher risk for skin progression (HR 1.10, 95% CI 1.00 to 1.22, p=0.046) and for 'any organ progression' (HR 1.07, 95% CI 1.00 to 1.13, p=0.036). In women, 34% of never-smokers were ATA-positive compared with 21% of ever-smokers (p<0.001). In the group of ever-smokers, higher exposure rates, reflected by the number of pack-years (OR 0.98, 95% CI 0.97 to 0.99, p<0.001) and by smoking duration (OR 0.96, 95% CI 0.95 to 0.97, p<0.001), were associated with lower frequency of ATA. In ACA-positive patients, the risk of mortality (HR 1.29, 95% CI 1.02 to 1.63, p=0.033), cardiac involvement (HR 1.25, 95% CI 1.03 to 1.43, p=0.001), skin progression (HR 1.21, 95% CI 1.03 to 1.42, p=0.018) and 'any organ progression' (HR 1.14, 95% CI 1.05 to 1.24, p=0.002) was increased among smokers. In ATA-positive smoking patients, mortality (HR 1.40, 95% CI 1.10 to 1.78, p=0.006), skin progression (HR 1.19, 95% CI 1.03 to 1.37, p=0.020) digital ulcers (HR 1.17, 95% CI 1.02 to 1.34, p=0.029) and 'any organ progression' (HR 1.11, 95% CI 1.00 to 1.22, p=0.048) occurred more frequently. CONCLUSIONS: Our stratified analysis demonstrates that smoking is associated with an increased risk for mortality in male SSc patients but not in women. Strikingly, smoking is associated with lower prevalence of ATA positivity, in particular in women. In both ATA-positive and ACA-positive patients, smoking is a risk factor for mortality, skin progression and 'any organ progression'.
引用
- Ciaffi J, Liem SIE, Cannegieter S, et al. Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort. RMD Open. 2024. PMID: 38772679. doi:10.1136/rmdopen-2024-004101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。